Chao Hong Hu
Keine laufenden Positionen mehr
Vermögen: 96 Mio $ am 30.04.2024
Profil
Chao Hong Hu was the founder and the Chairman & General Manager of Shanghai Miracogen, Inc., which was founded in 2014.
Dr. Hu also held the position of Co-Chief Executive Officer & Executive Director at Lepu Biopharma Co., Ltd.
from 2020 to 2024.
Prior to that, Dr. Hu worked as the Director-Molecular Biology & Clinical Immunology at ID Biomedical Corp.
Dr. Hu also served as the Director-Bioassay Development & Process Analytics at Seagen Inc. from 2007 to 2013, and as the Head-Molecular Biology & Clinical Immunology at GSK Plc in 2006.
Dr. Hu obtained an undergraduate degree from Wuhan University in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.12.2023 | 136 355 106 ( 8,49% ) | 96 Mio $ | 30.04.2024 |
Ehemalige bekannte Positionen von Chao Hong Hu
| Unternehmen | Position | Ende |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Vorstandsvorsitzender | 31.01.2024 |
| SEAGEN INC. | Corporate Officer/Principal | 01.10.2013 |
| GSK PLC | Corporate Officer/Principal | 01.05.2007 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01.01.2005 |
Shanghai Miracogen, Inc.
 Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Vorstandsvorsitzender | - |
Ausbildung von Chao Hong Hu
| Wuhan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| GSK PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
